WHAT IS EYSUVIS?
You’re looking for an eye drop that works fast*
and will help treat your Dry Eye and Dry Eye Flares. EYSUVIS can do that.
EYSUVIS is a prescription eye drop developed specifically
To treat Dry Eye SHORT-TERM
(UP TO 2 WEEKS)
- EYSUVIS contains a steroid called loteprednol etabonate (LO-tuh-PRED-nal e-TAB-uh-NATE)
a key cause
of Dry Eye:
EYSUVIS is an eye drop designed
short-term TREATMENT † in Dry Eye,
including the treatment of Dry Eye Flares.
EYSUVIS has been proven to treat both the signs (like redness)
and the Symptoms (like ocular discomfort or dryness) of Dry Eye.
HOW EYSUVIS CAN HELP
EYSUVIS is an effective eye drop that treats the signs and symptoms of Dry Eye and Dry Eye Flares.
It’s an eye drop that delivers quick* Dry Eye relief.
In clinical trials of more than 2,800 patients with Dry Eye, EYSUVIS effectively treated Dry Eye signs (like redness)
and Dry Eye symptoms (like ocular discomfort or dryness)
It’s an eye drop that targets inflammation,
a key cause of Dry Eye.
Inflammation is one of the key problems in Dry Eye. You may have tried over-the-counter eye drops, or artificial tears. They may give you relief, but it may be relief that doesn’t last. That’s because artificial tears don’t contain medicine and don't target inflammation
It’s an eye drop that provides short-term treatment † when you are having symptoms.
You may expect that you need to wait for Dry Eye relief. But you don’t. You can use EYSUVIS when you start feeling symptoms
and keep using it (as your eye care professional directs) for up to 2 weeks each time you experience Dry Eye Flares
Talk to your eye care professional about how EYSUVIS can help treat your Dry Eye and Dry Eye Flares.
HOW TO USE EYSUVIS
Getting Dry Eye relief with EYSUVIS takes only a few steps:
- If you wear contact lenses, remove them before using EYSUVIS.
- Remove outer cap by twisting it to the right.
- Shake the bottle for 2 to 3 seconds
- Remove the inner pink cap.DO NOT ALLOW THE DROPPER
TO TOUCH ANY SURFACE.
- Put 1 to 2 drop(s) into
- Put pink cap back onto the bottle.
- Wait 15 minutes before putting your contact lenses back in.
SAFETY AND SIDE EFFECTS
- The most common side effect of EYSUVIS was pain when the eye drops are put in the eye. This is not the only possible side effect.
Be sure to tell your eye care professional if you have any side effects that bother you
- DO NOT use EYSUVIS if you have an infection in your eye
- To help avoid infection, DO NOT allow the dropper tip to touch your eye or any other surface
- You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch(opens new window), or call 1-800-FDA-1088
When your eye care professional prescribes EYSUVIS, remember–
There is no generic substitute. Make sure your pharmacy gives you EYSUVIS.
*In a clinical trial program with 2871 patients with Dry Eye, patients using EYSUVIS showed significant reduction in the symptoms of Dry Eye (ocular discomfort) as early as Day 4 after starting treatment (versus placebo). Symptoms continued to improve up to the end of the treatment period (Day 15). Patients taking EYSUVIS also showed significant reduction in signs of Dry Eye (eye redness) at Day 15 versus placebo.
†Up to 14 days.
EYSUVIS should not be used if you have a viral infection in your eye. Talk to your doctor before using EYSUVIS if you think you may have a viral, bacterial, or fungal eye infection.
Your doctor should examine your eyes before prescribing EYSUVIS, to check for increased eye pressure or damage to the surface of the eye. Consult your doctor if pain, redness, itching, or inflammation develops or gets worse.
Wash your hands well before each use. Do not allow the dropper tip to touch any surface, as this may contaminate the suspension. Shake the bottle for two to three seconds before using. If a dose is missed, take the missed dose when remembered.
Remove contact lenses before using EYSUVIS; they may be reinserted 15 minutes later.
The most common adverse drug reaction following the use of EYSUVIS for two weeks was instillation site pain, which was reported in 5% of patients.
EYSUVIS is a corticosteroid indicated for the short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease.
Please see full Prescribing Information(opens a PDF document in a new window).